Shirasawa M, Yoshida T, Imabayashi T, Okuma K, et al. Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer. Eur J Cancer 2021;162:1-10.
PMID: 34936940